Montorip 150mg/100mg/500mg Capsule
By Montorip
Rx
4 Capsule in a Strip

Composition
Isoniazid(150mg) + Pyrazinamide(100mg) + Rifampicin(500mg)

Manufacturer - Shreya Life Sciences Pvt Ltd
SHREYA HOUSE, 301/A, Pereira Hill Road, Andheri East, Mumbai - 400 099, India

Expires on or after
October, 2025

liver
Montorip 150mg/100mg/500mg Capsule should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Montorip 150mg/100mg/500mg Capsule for patients with liver issues. It is important to consult your doctor before starting the treatment. Regular monitoring of liver function tests is recommended both before and during the course of treatment to ensure the medication is well-tolerated by the liver.

kidney
Montorip 150mg/100mg/500mg Capsule requires caution in kidney disease patients. Dosage adjustment may be necessary. Consult your doctor for guidance.

alcohol
When using Montorip 150mg/100mg/500mg Capsule, avoid consuming alcohol to prevent symptoms like flushing, increased heart rate, nausea, chest pain, thirst, and low blood pressure.

driving
When taking Montorip 150mg/100mg/500mg Capsule, be cautious while driving as it may cause dizziness, fainting, vision problems, or other side effects impacting driving ability.

pregnancy
Montorip 150mg/100mg/500mg Capsule may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Montorip 150mg/100mg/500mg Capsule can likely be used safely while breastfeeding. Studies show minimal risk to the baby based on limited human data available.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹16.63
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024